Skip to content
★ Sign in to follow
MH

Michael H. Tardugno

Executive
Chairman & CEO
Total declarations
64
Company
1
▲ Purchases (38 ops.)
€342k
▼ Sales (0 ops.)
—

Latest filing published 27 Oct 2026 for Imunon, Inc., €7,504.

Filing timeline

BuySale
Michael H. Tardugno

Insider track record

Disclosed buys
38
Disclosed sells
0
Signal history

Closed purchases

Market purchases
38
Positive at T+90
56%
Median T+90
+1.9%

Based on 16 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 16 Aug 2024 · 814 days ago · €23k
    -58.9%
    Entry US$15.78 · Close at T+365 US$6.48
  • Filed 12 Apr 2022 · 1671 days ago · €13k
    -69.0%
    Entry US$47.48 · Close at T+365 US$14.74
  • Filed 16 May 2019 · 2733 days ago · €9,666
    -34.1%
    Entry US$418.70 · Close at T+365 US$275.87
  • Filed 30 Oct 2018 · 2931 days ago · €14k
    -22.7%
    Entry US$412.83 · Close at T+365 US$318.91
  • Filed 09 Apr 2018 · 3135 days ago · €4,666
    -0.9%
    Entry US$446.09 · Close at T+365 US$442.17

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Michael H. Tardugno: trading record in brief

All filings by Michael H. Tardugno on record concern Imunon, Inc., in the capacity of chief executive. In total, 64 filings cover trades dated from 23 February 2007 to 23 October 2026.

On the market, this insider has only ever bought: 38 purchases, €342k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 22 share grants and 3 option exercises.

Half of the purchases are above €8,221 and half below. Clusters matter here: 9 out of 13 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 16 purchases show a median change of +1.9%, with the price up in 56% of them. They describe history only and say nothing certain about the share price ahead.

The latest filing, published on 27 October 2026, reports a share grant of €7,504 in Imunon, Inc. The last insider purchase was made public on 16 August 2024, 814 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Michael H. Tardugno

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations58 total
  • ◆
    Executive Chairman of BoardExecutivesImunon, Inc.
    8,424 USD0SEC
    6,821 shares@ US$1.235Common StockSEC:0001437749-26-033649:0
  • ◆
    Executive Chairman of BoardExecutivesImunon, Inc.
    8,424 USD34SEC
    7,800 shares@ US$1.080.14% mcap8.2% of flowCommon StockSEC:0001437749-26-032563:0
  • ◆
    Executive Chairman of BoardExecutivesImunon, Inc.
    10,108 USD34SEC
    7,169 shares@ US$1.410.13% mcap10.6% of flowCommon StockSEC:0001437749-26-031363:0
  • ◆
    Executive Chairman of BoardExecutivesImunon, Inc.
    8,561 USD33SEC
    5,824 shares@ US$1.470.15% mcap2.1% of flowCommon StockSEC:0001437749-26-030415:0
  • ◆
    Executive Chairman of BoardExecutivesImunon, Inc.
    11,794 USD34SEC
    7,371 shares@ US$1.600.15% mcap13.5% of flowCommon StockSEC:0001437749-26-029409:0
  • ◆
    Executive Chairman of BoardExecutivesImunon, Inc.
    11,793 USD34SEC
    7,147 shares@ US$1.650.15% mcap13.7% of flowCommon StockSEC:0001437749-26-028185:0
  • ◆
    Executive Chairman of BoardExecutivesImunon, Inc.
    10,109 USD34SEC
    6,358 shares@ US$1.590.13% mcap11.8% of flowCommon StockSEC:0001437749-26-025660:0
  • ◆
    Executive Chairman of BoardExecutivesImunon, Inc.
    8,423 USD33SEC
    4,603 shares@ US$1.830.11% mcap9.9% of flowCommon StockSEC:0001437749-26-023949:0
  • ◆
    Executive Chairman of BoardExecutivesImunon, Inc.
    8,423 USD33SEC
    4,410 shares@ US$1.910.11% mcap9.9% of flowCommon StockSEC:0001437749-26-022948:0
  • ◆
    Executive Chairman of BoardExecutivesImunon, Inc.
    0SEC
    42,519 sharesCommon StockSEC:0001437749-26-022003:0
  • ▲
    Executive Chairman of BoardExecutivesImunon, Inc.
    25,750 USD37SEC
    25,000 shares@ US$1.0331.4% of flowImunon Common StockSEC:0001437749-24-027058:0
    Canonical exit: 13 Nov 2024 (T+90)
  • ▲
    Chairman, President and CEOExecutivesImunon, Inc.
    14,129 USD42SEC
    4,000 shares@ US$3.5323100.0% of flowCelsion Corporation Common StockSEC:0001437749-22-008740:0
    Canonical exit: 11 Jul 2022 (T+90)
  • ◆
    Chairman, President and CEOExecutivesImunon, Inc.
    179,800 USD28SEC
    155,000 shares@ US$1.1658.9% of flowCelsion Corporation Common StockSEC:0001437749-20-003785:0
  • ▲
    Chairman, President and CEOExecutivesImunon, Inc.
    10,800 USD36SEC
    5,000 shares@ US$2.163.1% of flowCelssion Corporation Common StockSEC:0001437749-19-010232:0
    Canonical exit: 14 Aug 2019 (T+90)
  • ▲
    Chairman, President and CEOExecutivesImunon, Inc.
    15,450 USD38SEC
    7,500 shares@ US$2.064.2% of flowCelsion Corporation Common StockSEC:0001437749-18-019001:0
    Canonical exit: 27 Jan 2019 (T+90)
  • ▲
    Chairman, President and CEOExecutivesImunon, Inc.
    5,750 USD24SEC
    2,500 shares@ US$2.301.3% of flowCelsion Corporation Common StockSEC:0001437749-18-006524:0
    Canonical exit: 8 Jul 2018 (T+90)
  • ▲
    Chairman, President and CEOExecutivesImunon, Inc.
    17,850 USD40SEC
    7,500 shares@ US$2.384.1% of flowCelsion Corporation Common StockSEC:0001437749-18-003864:0
    Canonical exit: 3 Jun 2018 (T+90)
  • ▲
    Chairman, President and CEOExecutivesImunon, Inc.
    11,400 USD28SEC
    10,000 shares@ US$1.142.9% of flowCelsion Corporation Common StockSEC:0001437749-16-039653:0
    Canonical exit: 5 Jan 2017 (T+90)
  • ▲
    Chairman, President and CEOExecutivesImunon, Inc.
    6,250 USD40SEC
    5,000 shares@ US$1.251.6% of flowCelsion Corporation Common StockSEC:0001437749-16-037641:0
    Canonical exit: 14 Nov 2016 (T+90)
  • ▲
    Chairman, President and CEOExecutivesImunon, Inc.
    10,125 USD28SEC
    7,500 shares@ US$1.352.5% of flowCelsion Corporation Common StockSEC:0001437749-16-033977:0
    Canonical exit: 14 Sept 2016 (T+90)
  • ▲
    CEOExecutivesImunon, Inc.
    3,810 USD40SEC
    3,000 shares@ US$1.271.0% of flowCelsion Corporation Common StockSEC:0001437749-16-025704:0
    Canonical exit: 19 May 2016 (T+90)
  • ▲
    CEOExecutivesImunon, Inc.
    2,540 USD38SEC
    2,000 shares@ US$1.270.6% of flowCelsion Corporation Common StockSEC:0001437749-16-025523:0
    Canonical exit: 17 May 2016 (T+90)
  • ▲
    CEOExecutivesImunon, Inc.
    5,396 USD36SEC
    4,500 shares@ US$1.1994.2% of flowCelsion Corporation Common StockSEC:0001437749-16-025457:0
    Canonical exit: 16 May 2016 (T+90)
  • ▲
    CEOExecutivesImunon, Inc.
    7,313 USD23SEC
    6,500 shares@ US$1.1255.6% of flowCelsion Corporation Common StockSEC:0001437749-16-025297:0
    Canonical exit: 12 May 2016 (T+90)
  • ◆
    CEOExecutivesImunon, Inc.
    0SEC
    25,000 sharesCelsion Corporation Common StockSEC:0001437749-16-024792:0

25 of 58 declarations